✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Viyash Scientific Ltd.

SEQUENT

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹9,322 Cr.
P/E
222.96

Viyash Scientific Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
9,322 Cr
PE
PE
222
Prom Holding
Prom Holding
61.41 %
ROE (%)
ROE (%)
3.11
ROCE (%)
ROCE (%)
10.65
Div Yield (%)
Div Yield (%)
0.03
Sales
Sales
1,657 Cr
OPM (%)
OPM (%)
11.38 %
Debt to Equity
Debt to Equity
0.73
View more
Edit Ratio's

About

SeQuent, an integrated pharmaceutical company founded in 2002, focuses on Animal Health (API a… Read more
Low
111
52W Range
High
260
  • Viyash Scientific
  • Procter&Gamble Healt
  • Sanofi India
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

10 %
(as of Mar 19)
Source/Historic
Animal Healthcare - Market Share in Turkey
30 %
(as of Mar 19)
Source/Historic
Losartan - Market Share in USA

Revenue mix

Product Wise Break-Up

Segment Break-Up - Formulation Business-By Dosage

Segment Break-Up - Formulation Business-By Species Type

Location Wise Break-Up - Formulations

Location Wise Break-Up

Therapeutic Area Break-Up - Formulations

Customer Segment

Dosage Form Break-Up

R&D Break-Up - Product Wise

Asset Break-Up

Species Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Viyash Scientific Ltd. Business

    SeQuent, operating as Alivira Animal Health, is a global pharmaceutical company established in 2002. It focuses on developing products for livestock, poultry, and companion animals to create value in the animal health space.

    Viyash Scientific major competitors are Procter&Gamble Healt, Sanofi India, Strides Pharma Scien, Marksans Pharma, FDC, Zota Health Care, Caplin Point Lab.
    Market Cap of Viyash Scientific is ₹8,890 Crs.
    While the median market cap of its peers are ₹7,702 Crs.

    Viyash Scientific seems to be less financially stable compared to its competitors.
    Altman Z score of Viyash Scientific is 8.06 and is ranked 5 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Viyash Scientific Ltd.
    Animal Healthcare & Sequent Scientific - Deep Dive - Scientific Investing
    Sequent | A Hidden Niche - SOIC
    Sequent Scientific | India’s Largest Pure-play Animal Health Company - Value Educator
    View the discussion on ValuePickr
    SequentScientific FY 2022 Annual Report Highlights - Value Educator
    Pharmaceuticals
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material